Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAAL: Pyronaridine-artesunate vs Artemether-lumefantrine for Paediatric Malaria in Kenya
NCT02411994Phase 3Completed
- Sponsor
- Royal Tropical Institute
- Start
- Oct 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of artesunate + pyronaridine in malaria, sponsored by Royal Tropical Institute. Started Oct 2015; status: completed.
02
Drugs
artesunate + pyronaridine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02411994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02411994.